These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19713605)

  • 61. [Baseline and contrast-enhanced ultrasound of the liver in tumor patients].
    Oldenburg A; Albrecht T
    Ultraschall Med; 2008 Oct; 29(5):488-98. PubMed ID: 19241505
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography.
    Maruyama H; Takahashi M; Ishibashi H; Okugawa H; Okabe S; Yoshikawa M; Yokosuka O
    Liver Int; 2009 May; 29(5):708-14. PubMed ID: 18803588
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Contrast-enhanced sonography in the characterization of small hepatocellular carcinomas in cirrhotic patients: comparison with contrast-enhanced ultrafast magnetic resonance imaging.
    Giorgio A; De Stefano G; Coppola C; Ferraioli G; Esposito V; Di Sarno A; Giorgio V; De Stefano M; Sangiovanni V; Liorre G; Del Viscovo L
    Anticancer Res; 2007; 27(6C):4263-9. PubMed ID: 18214030
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions.
    Furuse J; Nagase M; Ishii H; Yoshino M
    Br J Radiol; 2003 Jun; 76(906):385-92. PubMed ID: 12814924
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Native and signal-enhanced power Doppler sonography for characterization of liver lesions].
    Strunk H; Stuckmann G; Fröhlich E; Textor J; Wilhelm K; Hortling N; Remig J
    Rofo; 1998 Apr; 168(4):344-51. PubMed ID: 9589096
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Focal liver lesions: can SonoVue-enhanced ultrasound be used to differentiate malignant from benign lesions?
    Dai Y; Chen MH; Yin SS; Yan K; Fan ZH; Wu W; Wang YB; Yang W
    Invest Radiol; 2007 Aug; 42(8):596-603. PubMed ID: 17620943
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
    Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
    Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Color Doppler sonography of focal abdominal lesions].
    Licanin Z; Lincender L; Djurović V; Salihefendić N; Smajlović F
    Med Arh; 2004; 58(1 Suppl 2):119-21. PubMed ID: 15137225
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Value of liver parenchymal phase contrast-enhanced sonography to diagnose premalignant and borderline lesions and overt hepatocellular carcinoma.
    Inoue T; Kudo M; Maenishi O; Komuta M; Nakashima O; Kojiro M; Maekawa K
    AJR Am J Roentgenol; 2009 Mar; 192(3):698-705. PubMed ID: 19234266
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Three-dimensional contrast-enhanced sonography of vascular patterns of focal liver tumors: pilot study of visualization methods.
    Luo W; Numata K; Morimoto M; Nozaki A; Nagano Y; Sugimori K; Tanaka K
    AJR Am J Roentgenol; 2009 Jan; 192(1):165-73. PubMed ID: 19098197
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging.
    Hayashida M; Ito K; Fujita T; Shimizu A; Sasaki K; Tanabe M; Matsunaga N
    Magn Reson Imaging; 2008 Jan; 26(1):65-71. PubMed ID: 17566685
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The dynamic enhanced characterization with low mechanical index gray-scale harmonic imaging inflammatory pseudotumor of liver compared with hepatic VX2 tumor and normal liver.
    Shi Y; Wang X; Qiao Y; Bai X; Wang Q; Lei C
    Adv Clin Exp Med; 2020 Sep; 29(9):1073-1081. PubMed ID: 32886457
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A.
    Dietrich CF; Ignee A; Trojan J; Fellbaum C; Schuessler G
    Gut; 2004 Mar; 53(3):401-5. PubMed ID: 14960524
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Focal Lesions in Fatty Liver: If Quantitative Analysis Facilitates the Differentiation of Atypical Benign from Malignant Lesions.
    Shan QY; Chen LD; Zhou LY; Wang Z; Liu GJ; Huang Y; Li W; Liu JY; Xie XY; Lu MD; Liu J; Wang W
    Sci Rep; 2016 Jan; 6():18640. PubMed ID: 26725923
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of visual and quantitative analysis for characterization of insonated liver tumors after microbubble contrast injection.
    Quaia E; Palumbo A; Rossi S; Degobbis F; Cernic S; Tona G; Cova M
    AJR Am J Roentgenol; 2006 Jun; 186(6):1560-70. PubMed ID: 16714644
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of Liver Metastases Using Contrast-Enhanced Ultrasound: Enhancement Patterns and Influencing Factors.
    Kong WT; Ji ZB; Wang WP; Cai H; Huang BJ; Ding H
    Gut Liver; 2016 Mar; 10(2):283-7. PubMed ID: 26586554
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Contrast ultrasound imaging in focal liver lesions: diagnostic value and guidelines].
    Tranquart F; Bleuzen A; Tchuenbou J
    J Radiol; 2004 May; 85(5 Pt 2):680-9. PubMed ID: 15238869
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Contrast-enhanced ultrasound and its differential diagnosis in 21 patients with intrahepatic space-occupying lesions under the background of fatty liver.
    Luo Y; Yue W; Li Z; Wang P
    Ann Palliat Med; 2021 Mar; 10(3):3097-3104. PubMed ID: 33752424
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Parametric imaging for characterizing focal liver lesions in contrast-enhanced ultrasound.
    Rognin NG; Arditi M; Mercier L; Frinking PJ; Schneider M; Perrenoud G; Anaye A; Meuwly JY; Tranquart F
    IEEE Trans Ultrason Ferroelectr Freq Control; 2010 Nov; 57(11):2503-11. PubMed ID: 21041137
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Early experience in the use of Levovist ultrasound contrast in the evaluation of liver masses.
    Plew J; Sanki J; Young N; Gruenewald S; Dwyer R; Brancatisano R
    Australas Radiol; 2000 Feb; 44(1):28-31. PubMed ID: 10761256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.